The company said revenues for Q1 2024 totaled $17.339 billion (Q1 2023 $15.591 billion), and net income attributable to HCA Healthcare, Inc. totaled $1.591 billion ($5.93 per diluted share).

1. 01

   The company said revenues for Q1 2024 totaled $17.339 billion (Q1 2023 $15.591 billion), and net income attributable to HCA Healthcare, Inc. totaled $1.591 billion ($5.93 per diluted share).

2. 02

   HCA said Adjusted EBITDA for Q1 totaled $3.353 billion (compared with $3.172 billion a year earlier), and its results for Q1 included gains on sales of facilities of $201 million ($0.57 per share).

3. 03

   Hospital operator HCA said cash flows from operating activities for Q1 totaled $2.469 billion (compared with $1.803 billion a year earlier), that it repurchased 3.894 million shares of common stock at a cost of $1.180 billion, and that it had $5.595 billion remaining under its repurchase authorization as of March 31.

4. 04

   The company declared a quarterly cash dividend of $0.66 per share, reaffirmed its 2024 full-year guidance ranges issued on January 30, and said its full-year revenue outlook is $67,750 million to $70,250 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.